This briefing was released on November 30, 2017, by the Minnesota Department of Health. The briefing was prepared in response to a petition to add autism as a new condition to the list of qualifying conditions for the Minnesota medical cannabis program. The briefing presents the outcomes of clinical trials and observational studies about use for cannabis to address symptoms of the proposed new condition . . .
This article is reserved for members with an active Standard Membership. Please purchase a Standard Membership to view this resource.
15 Lincoln Square, Gettysburg, PA 17325-1933
Get OPEN MINDS market intelligence and management best practices everyday via email. Sign up free below:
© 2018 OPEN MINDS
Call our toll-free phone number 877-350-6463